Tag:
dalcetrapid
Latest Headlines
Latest Headlines
Roche HDL drug dalcetrapib clears a crucial safety test
Roche appears to have navigated safe passage around a couple of the clinical landmines awaiting any mid-stage HDL study, noting that data from their Phase II trial of dalcetrapib demonstrated that
Roche abstract paints promising picture of a potential mega-blockbuster
A scientific abstract prepared for next week's meeting of the European Society of Cardiology in Paris tipped off analysts over the weekend to some positive mid-stage data on dalcetrapib, Roche's
Roche targets 'good cholesterol' drug win where rivals failed
The pressure is on. With its good-cholesterol raising drug, Roche has a shot to advance a whole new class of blockbuster heart pills--or become another firm to crash and burn in the high-risk field.
